Notably, previous studies have identified NRP1 as part of an eight-protein serum panel that effectively distinguished PAH patients from non-PH patients using machine learning-based proteomic profiling (Bauer et al. 2021). Here, NRP1 is linked to pulmonary arterial hypertension.